The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen

Open Access

Reader Comments (0)

Cardiovascular therapy
Is the Subject Area "Cardiovascular therapy" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Safety studies
Is the Subject Area "Safety studies" applicable to this article?

Thanks for your feedback.
Antigen-presenting cells
Is the Subject Area "Antigen-presenting cells" applicable to this article?

Thanks for your feedback.
Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Medical ethics
Is the Subject Area "Medical ethics" applicable to this article?

Thanks for your feedback.
Reflection
Is the Subject Area "Reflection" applicable to this article?

Thanks for your feedback.